Anika Therapeutics Q2 Adj. EPS $0.42 May Not Compare To $(0.08) Estimate, Sales $32.610M Beat $29.215M Estimate

Loading news article.

Anika Therapeutics Q2 Adj. EPS $0.42 May Not Compare To $(0.08) Estimate, Sales $32.610M Beat $29.215M Estimate | WAPE

Article summary